Apheresis to Mitigate Atherosclerotic Vascular Disease
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Hypertension"
DOI: 10.1093/ajh/hpy068
Abstract: BACKGROUND Therapeutic apheresis is a term used to describe a group of treatments where blood components are separated in real time, and one component is removed, exchanged, and/or treated to remove pathogenic substances from the… read more here.
Keywords: apheresis mitigate; lipid apheresis; atherosclerotic vascular; apheresis ... See more keywords
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Sign Up to like & getrecommendations! Published in 2022 at "BMC Pediatrics"
DOI: 10.1186/s12887-022-03192-7
Abstract: Background Homozygous familial hypercholesterolemia (hoFH) is a rare genetic disorder leading to extremely increased LDL-cholesterol (LDL-C), resulting in high cardiovascular risk in early childhood. Lipid apheresis (LA) is an effective treatment and should be started… read more here.
Keywords: lipid apheresis; vascular access; access; young children ... See more keywords
The Effect of 4-Methylcatechol on Platelets in Familial Hypercholesterolemic Patients Treated with Lipid Apheresis and/or Proprotein Convertase Subtilisin Kexin 9 Monoclonal Antibodies
Sign Up to like & getrecommendations! Published in 2023 at "Nutrients"
DOI: 10.3390/nu15081842
Abstract: Elevated low-density lipoprotein (LDL) cholesterol levels lead to atherosclerosis and platelet hyperaggregability, both of which are known culprits of arterial thrombosis. Normalization of LDL cholesterol in familial hypercholesterolemia (FH) is not an easy task and… read more here.
Keywords: kexin monoclonal; effect; subtilisin kexin; proprotein convertase ... See more keywords